| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 947 | 1,990 | 2,838 | 2,944 | | Cost of Revenue | 840 | 1,230 | 1,538 | 1,463 | | | Gross Profit | 107 | 760 | 1,300 | 1,481 | | | Operating Expenses | | Research Development | 1,143 | 1,920 | 1,893 | 2,079 | | Selling General and Administrative | 1,604 | 2,344 | 3,287 | 4,109 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,640) | (3,504) | (3,880) | (4,707) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6 | 10 | 8 | 40 | | Earnings Before Interest And Taxes | (2,634) | (3,494) | (3,872) | (4,667) | | Interest Expense | 30 | 30 | 30 | 30 | | Income Before Tax | (2,664) | (3,524) | (3,902) | (4,697) | | Income Tax Expense |
-
| (72) |
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,664) | (3,452) | (3,902) | (4,697) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,664) | (3,452) | (3,902) | (4,697) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,664) | ($3,452) | ($3,902) | ($4,697) |
|
0.31% Nasdaq 
0.05%
Income Statement
